NOVEL NANOTHERAPEUTICS FOR COMBATTING PNEUMONIC PLAGUE
$4,390,206
| Recipient | EITR BIOLOGICS, INC. UEI HX49LZLY32G5 |
|---|---|
| Award ID | HT942523D0011 |
| Award amount | $4,390,206 |
| Award type | — |
| Awarding agency | Department of Defense — Defense Health Agency |
| NAICS | 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| PSC | AJ11 |
| Start date | Aug 15, 2023 |
| End date | — |
| Place of performance | — |
| Record updated | Aug 15, 2023 |
View the official award record
More awards won by EITR BIOLOGICS, INC.
THE DEVELOPMENT OF A MULTIMODAL ANTIBODY PLATFORM TO EXTEND THE WINDOW OF IMMUNOTHERAPEUTIC INTERVENTION. THE OVERALL OBJECTIVE OF THE WORK OUTLINED IN THIS CONTRACT IS TO CRITICALLY EVALUATE THE UTILITY OF THE VHH AS A PLATFORM MCM TECHNOLOGY FOR VI
Department of Health and Human Services · $26,614,177 · Sep 22, 2023
NOVEL NANOTHERAPEUTICS
Department of Defense · $1,864,756 · Sep 20, 2024
NOVEL CELL SORTING
Department of Defense · $1,105,767 · Nov 28, 2022
NOVEL BISPECIFIC BROAD SPECTRUM NANOBODY
Department of Defense · $926,999 · Feb 1, 2026
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids